License cancellation trial on liquid-type Uwangchungsimwon is in favor of Chosun Pharm

The Seoul High Court ruled that the administrative disposition of the Korea Food and Drug Administration (KFDA) on Chosun's Uwangchungsimwon is deemed unfair, in a recent lawsuit raised by Chosun Pharm against the license cancellation of its Uwangchungsimwon in liquid form imposed by the KFDA, claiming that insufficient contents of active ingredient were found in some of the previously manufact...